Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/24/15 → 07/23/17 |
Funding
- MAST Therapeutics Incorporated: $59,915.00
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188
- Abeles, Jennifer (CoI)
- Jain, Shilpa (PI)
Project: Research